Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Non-Current Assets (2016 - 2025)

Bio-Techne has reported Non-Current Assets over the past 17 years, most recently at $1.9 billion for Q4 2025.

  • Quarterly results put Non-Current Assets at $1.9 billion for Q4 2025, down 7.39% from a year ago — trailing twelve months through Dec 2025 was $7.9 billion (down 6.2% YoY), and the annual figure for FY2025 was $245.7 million, down 2.16%.
  • Non-Current Assets for Q4 2025 was $1.9 billion at Bio-Techne, down from $1.9 billion in the prior quarter.
  • Over the last five years, Non-Current Assets for TECH hit a ceiling of $2.2 billion in Q3 2023 and a floor of $207.9 million in Q2 2021.
  • Median Non-Current Assets over the past 5 years was $1.8 billion (2022), compared with a mean of $1.5 billion.
  • Biggest five-year swings in Non-Current Assets: increased 20.3% in 2023 and later dropped 8.18% in 2025.
  • Bio-Techne's Non-Current Assets stood at $1.7 billion in 2021, then increased by 4.88% to $1.8 billion in 2022, then grew by 19.01% to $2.1 billion in 2023, then dropped by 4.87% to $2.0 billion in 2024, then decreased by 7.39% to $1.9 billion in 2025.
  • The last three reported values for Non-Current Assets were $1.9 billion (Q4 2025), $1.9 billion (Q3 2025), and $245.7 million (Q2 2025) per Business Quant data.